Stock Evaluator: Concord Medical Services Holdings Limited (CCM)

Concord Medical Services Holdings Limited CCM

$4.43 -0.23 -4.84%
July 31, 2026 1:58:45 PM EST November 10, 2021 Volume: 2,397
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Commentary & Analysis


Financial Summary

Share Statistics CCM Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $19.2 $1,742.7 10%
Shares Out (Mil) 0.6 76.7 3%
Institutional Ownership 1.6% 89.7% 3%
Float (Mil) 1.4 49.4 3%
Beta -0.97 0.82 1%
Avg Daily Volume (000s) 53 521 29%
Price Change
(52-week)
(19.4%) 78.7% 31%
Growth CCM Industry
Median
Percentile
(All Stocks)
Sales (5yr) 14.0% 11.0% 70%
Net Income (5yr) 22.5% (0.7%) 76%
EPS (5yr) 33.6% 3.1% 84
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (30.2%) (18.0%) 19%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials CCM Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $66 $1,456 22%
Net Income (TTM) (Mil) ($13) $12 27%
EPS (TTM) ($3.038) $0.300 11%
Operating Cash Flow (TTM) (Mil) na $138 na
Net Cash Flow (TTM) (Mil) na $8 na
Long-Term Debt (Q1) (Mil) $373 $316 56%
Enterprise Value (Q1) (Mil) $1,063 $2,170 42%
Valuation CCM Industry
Median
Percentile
(All Stocks)
P/B na 2.85 na
P/E na 26.7 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios CCM Industry
Median
Percentile
(All Stocks)
Gross Margin 5.6% 27.8% 6%
Net Margin (20.2%) 1.1% 17%
ROA (1.5%) 1.8% 35%
ROE 4.4% 7.1% 43%
Liabilities to Assets 71.7% 59.9% 67%
F-Score 3 5 19%

Concord Medical Services Holdings Limited did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors